CYCLO THERAPEUTICS, INC. Proceeds from Warrant Exercises
CYCLO THERAPEUTICS, INC. reported Proceeds from Warrant Exercises of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2024-12-18
- CYCLO THERAPEUTICS, INC. proceeds from warrant exercises for the quarter ending 2024-09-30 was $0.00.
- CYCLO THERAPEUTICS, INC. proceeds from warrant exercises for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- CYCLO THERAPEUTICS, INC. proceeds from warrant exercises for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- CYCLO THERAPEUTICS, INC. proceeds from warrant exercises for the quarter ending 2023-12-31 was $2.39M.
- CYCLO THERAPEUTICS, INC. proceeds from warrant exercises for fiscal 2023 was $2.39M.
- CYCLO THERAPEUTICS, INC. proceeds from warrant exercises for fiscal 2022 was $0.00.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $2.39M derived: sum of 4 quarters · filed 2024-12-18 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $2.39M derived: sum of 3 quarters · filed 2024-12-18 | $2.39M derived: sum of 4 quarters · filed 2024-12-18 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $2.39M derived: sum of 2 quarters · filed 2024-12-18 | $2.39M derived: sum of 3 quarters · filed 2024-12-18 | $2.39M derived: sum of 4 quarters · filed 2024-12-18 |
| 2023-12-31 | $2.39M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-18 | $2.39M derived: sum of 2 quarters · filed 2024-12-18 | $2.39M derived: sum of 3 quarters · filed 2024-12-18 | $2.39M 10-K/A · filed 2024-12-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $54.00 derived: sum of 2 quarters · filed 2024-11-14 | $168.00 10-Q · filed 2024-11-14 | $168.00 derived: sum of 4 quarters · filed 2024-12-18 |
| 2023-06-30 | $54.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $168.00 10-Q · filed 2024-08-14 | $168.00 derived: sum of 3 quarters · filed 2024-12-18 | $168.00 derived: sum of 4 quarters · filed 2024-12-18 |
| 2023-03-31 | $114.00 10-Q · filed 2024-05-15 | $114.00 derived: sum of 2 quarters · filed 2024-12-18 | $114.00 derived: sum of 3 quarters · filed 2024-12-18 | $114.00 derived: sum of 4 quarters · filed 2024-12-18 |
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-18 | $0.00 derived: sum of 2 quarters · filed 2024-12-18 | $0.00 derived: sum of 3 quarters · filed 2024-12-18 | $0.00 10-K/A · filed 2024-12-18 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2021-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $407.01K derived: sum of 2 quarters · filed 2022-11-10 | $7.99M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $402.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $7.99M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $7.58M 10-Q · filed 2022-05-12 |